Literature DB >> 23823199

Mechanisms of acute respiratory distress syndrome in children and adults: a review and suggestions for future research.

Lincoln S Smith1, Jerry J Zimmerman, Thomas R Martin.   

Abstract

OBJECTIVES: To provide a current overview of the epidemiology and pathophysiology of acute respiratory distress syndrome in adults and children, and to identify research questions that will address the differences between adults and children with acute respiratory distress syndrome. DATA SOURCES: Narrative literature review and author-generated data. DATA SELECTION: The epidemiology of acute respiratory distress syndrome in adults and children, lung morphogenesis, and postnatal lung growth and development are reviewed. The pathophysiology of acute respiratory distress syndrome is divided into eight categories: alveolar fluid transport, surfactant, innate immunity, apoptosis, coagulation, direct alveolar epithelial injury by bacterial products, ventilator-associated lung injury, and repair. DATA EXTRACTION AND SYNTHESIS: Epidemiologic data suggest significant differences in the prevalence and mortality of acute respiratory distress syndrome between children and adults. Postnatal lung development continues through attainment of adult height, and there is overlap between the regulation of postnatal lung development and inflammatory, apoptotic, alveolar fluid clearance, and repair mechanisms. Therefore, there is a different biological baseline network of gene and protein expression in children as compared with adults.
CONCLUSIONS: There are significant obstacles to performing research on children with acute respiratory distress syndrome. However, epidemiologic, clinical, and animal studies suggest age-dependent differences in the pathophysiology of acute respiratory distress syndrome. In order to reduce the prevalence and improve the outcome of patients with acute respiratory distress syndrome, translational studies of inflammatory, apoptotic, alveolar fluid clearance, and repair mechanisms are needed. Understanding the differences in pathophysiologic mechanisms in acute respiratory distress syndrome between children and adults should facilitate identification of novel therapeutic interventions to prevent or modulate lung injury and improve lung repair.

Entities:  

Mesh:

Year:  2013        PMID: 23823199     DOI: 10.1097/PCC.0b013e318291753f

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  24 in total

1.  Evaluating the Berlin Definition in pediatric ARDS.

Authors:  Robinder G Khemani; Douglas F Wilson; Andrés Esteban; Niall D Ferguson
Journal:  Intensive Care Med       Date:  2013-10-08       Impact factor: 17.440

Review 2.  Pulmonary epithelial barrier function: some new players and mechanisms.

Authors:  Kieran Brune; James Frank; Andreas Schwingshackl; James Finigan; Venkataramana K Sidhaye
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-01-30       Impact factor: 5.464

3.  Early Use of Adjunctive Therapies for Pediatric Acute Respiratory Distress Syndrome: A PARDIE Study.

Authors:  Courtney M Rowan; Margaret J Klein; Deyin Doreen Hsing; Mary K Dahmer; Philip C Spinella; Guillaume Emeriaud; Amanda B Hassinger; Byron E Piñeres-Olave; Heidi R Flori; Bereketeab Haileselassie; Yolanda M Lopez-Fernandez; Ranjit S Chima; Steven L Shein; Aline B Maddux; Jon Lillie; Ledys Izquierdo; Martin C J Kneyber; Lincoln S Smith; Robinder G Khemani; Neal J Thomas; Nadir Yehya
Journal:  Am J Respir Crit Care Med       Date:  2020-06-01       Impact factor: 21.405

4.  Lugrandoside attenuates LPS-induced acute respiratory distress syndrome by anti-inflammation and anti-apoptosis in mice.

Authors:  Chengbao Li; Ying Huang; Xueya Yao; Baoji Hu; Suzhen Wu; Guannan Chen; Xin Lv; Fubo Tian
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

5.  Interleukin-1 Receptor Antagonist Is Associated With Pediatric Acute Respiratory Distress Syndrome and Worse Outcomes in Children With Acute Respiratory Failure.

Authors:  Mary K Dahmer; Michael W Quasney; Anil Sapru; Ginny Gildengorin; Martha A Q Curley; Michael A Matthay; Heidi Flori
Journal:  Pediatr Crit Care Med       Date:  2018-10       Impact factor: 3.624

6.  Activation of SIRT1 ameliorates LPS-induced lung injury in mice via decreasing endothelial tight junction permeability.

Authors:  Cuiping Fu; Shengyu Hao; Xiaobo Xu; Jian Zhou; Zilong Liu; Huan Lu; Limin Wang; Weizhong Jin; Shanqun Li
Journal:  Acta Pharmacol Sin       Date:  2018-07-18       Impact factor: 6.150

7.  Maresin 1 Maintains the Permeability of Lung Epithelial Cells In Vitro and In Vivo.

Authors:  Lin Chen; Hong Liu; Yaxin Wang; Haifa Xia; Jie Gong; Bo Li; Shanglong Yao; You Shang
Journal:  Inflammation       Date:  2016-12       Impact factor: 4.092

8.  Regulation of inflammatory biomarkers by intravenous methylprednisolone in pediatric ARDS patients: Results from a double-blind, placebo-controlled randomized pilot trial.

Authors:  Andreas Schwingshackl; Dai Kimura; Cynthia R Rovnaghi; Jordy S Saravia; Stephania A Cormier; Bin Teng; Alina N West; Umberto G Meduri; Kanwaljeet J S Anand
Journal:  Cytokine       Date:  2015-11-03       Impact factor: 3.861

Review 9.  Paediatrics: how to manage acute respiratory distress syndrome.

Authors:  Kam Lun Hon; Karen Ka Yan Leung; Felix Oberender; Alexander Kc Leung
Journal:  Drugs Context       Date:  2021-06-01

Review 10.  Progress and perspectives in pediatric acute respiratory distress syndrome.

Authors:  Alexandre Tellechea Rotta; Jefferson Pedro Piva; Cinara Andreolio; Werther Brunow de Carvalho; Pedro Celiny Ramos Garcia
Journal:  Rev Bras Ter Intensiva       Date:  2015-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.